Daniel Brinton to Mucocutaneous Lymph Node Syndrome
This is a "connection" page, showing publications Daniel Brinton has written about Mucocutaneous Lymph Node Syndrome.
Connection Strength
0.375
-
Assessing Health Care Utilization and Compliance in Kawasaki Disease. J Pediatr. 2021 Jul; 234:181-186.e1.
Score: 0.189
-
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.
Score: 0.186